SOSatoshi Ohta

Satoshi Ohta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Satoshi Ohta has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    STK38 Kinase Promotes Cell Migration Induced by Oncogenic Ras via MerTK Activation

    by Satoshi Ohta, Kenji Tago, Katsumi Kasashima, Masayuki Ebina, Kaoru Tominaga

    Ras gene mutations are frequently observed in many types of cancers. However, there are currently no effective anticancer drugs against Ras-induced cancers. Therefore, identifying the downstream effectors of the Ras signaling pathway can facilitate the development of promising novel therapeutic approaches. We previously showed that oncogenic Ras induces the expression of the receptor tyrosine kinase c-Mer proto-oncogene tyrosine kinase (MerTK) in an interleukin-1 family member NF-HEV/IL-33-dependent manner and that IL-33 and MerTK contribute to oncogenic Ras-induced cell migration. In the present study, we purified the MerTK complex from NIH-3T3 cells transformed by the expression of oncogenic Ras, H-Ras (G12V). Mass spectrometric analysis identified STK38 (also known as NDR1) as a candidate binding partner for MerTK. STK38 is a serine/threonine protein kinase that plays diverse roles in normal and cancerous cells. In addition to MerTK knockdown, STK38 knockdown effectively attenuated the H-Ras (G12V)-induced migration of NIH-3T3 cells. STK38 kinase activity is required for oncogenic Ras-induced cell migration and MerTK tyrosine phosphorylation. Furthermore, MerTK or STK38 knockdown attenuated the activation of Rac1 and Cdc42. Taken together, these results revealed a novel role for STK38 in oncogenic Ras-induced enhanced cell migration, which may be useful for developing novel therapeutic strategies targeting Ras-mutated cells.


  • Open Access

    Production and Characterization of Self-Assembled Virus-like Particles Comprising Capsid Proteins from Genotypes 3 and 4 Hepatitis E Virus (HEV) and Rabbit HEV Expressed in Escherichia coli

    by Tominari Kobayashi, Masaharu Takahashi, Satoshi Ohta, Yu Hoshino, Kentaro Yamada, Suljid Jirintai, Putu Prathiwi Primadharsini, Shigeo Nagashima, Kazumoto Murata, Hiroaki Okamoto

    The zoonotic transmission of hepatitis E virus (HEV) genotypes 3 (HEV-3) and 4 (HEV-4), and rabbit HEV (HEV-3ra) has been documented. Vaccination against HEV infection depends on the capsid (open reading frame 2, ORF2) protein, which is highly immunogenic and elicits effective virus-neutralizing antibodies. Escherichia coli (E. coli) is utilized as an effective system for producing HEV-like particles (VLPs). However, research on the production of ORF2 proteins from these HEV genotypes in E. coli to form VLPs has been modest. In this study, we constructed 21 recombinant plasmids expressing various N-terminally and C-terminally truncated HEV ORF2 proteins for HEV-3, HEV-3ra, and HEV-4 in E. coli. We successfully obtained nine HEV-3, two HEV-3ra, and ten HEV-4 ORF2 proteins, which were primarily localized in inclusion bodies. These proteins were solubilized in 4 M urea, filtered, and subjected to gel filtration. Results revealed that six HEV-3, one HEV-3ra, and two HEV-4 truncated proteins could assemble into VLPs. The purified VLPs displayed molecular weights ranging from 27.1 to 63.4 kDa and demonstrated high purity (74.7–95.3%), as assessed by bioanalyzer, with yields of 13.9–89.6 mg per 100 mL of TB medium. Immunoelectron microscopy confirmed the origin of these VLPs from HEV ORF2. Antigenicity testing indicated that these VLPs possess characteristic HEV antigenicity. Evaluation of immunogenicity in Balb/cAJcl mice revealed robust anti-HEV IgG responses, highlighting the potential of these VLPs as immunogens. These findings suggest that the generated HEV VLPs of different genotypes could serve as valuable tools for HEV research and vaccine development.


  • Open Access

    FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5

    by Kengo Takeda, Satoshi Ohta, Miu Nagao, Erika Kobayashi, Kenji Tago, Megumi Funakoshi-Tago

    Chronic myeloid leukemia (CML) is induced by the expression of the fused tyrosine kinase BCR-ABL, which is caused by a chromosomal translocation. BCR-ABL inhibitors have been used to treat CML; however, the acquisition of resistance by CML cells during treatment is a serious issue. We herein demonstrated that BCR-ABL induced the expression of the RNA helicase DDX5 in K562 cells derived from CML patients in a manner that was dependent on its kinase activity, which resulted in cell proliferation and survival. The knockout of DDX5 decreased the expression of BIRC5 (survivin) and activated caspase 3, leading to apoptosis in K562 cells. Similar results were obtained in cells treated with FL118, an inhibitor of DDX5 and a derivative compound of camptothecin (CPT). Furthermore, FL118 potently induced apoptosis not only in Ba/F3 cells expressing BCR-ABL, but also in those expressing the BCR-ABL T315I mutant, which is resistant to BCR-ABL inhibitors. Collectively, these results revealed that DDX5 is a critical therapeutic target in CML and that FL118 is an effective candidate compound for the treatment of BCR-ABL inhibitor-resistant CML.


  • Open Access

    Development of Acid Citrus Cultivar Identification System by SNP Markers

    by Eri Niimi, Hiroshi Fujii, Satoshi Ohta, Takuya Iwakura, Tomoko Endo, Takehiko Shimada

    香酸カンキツの果実は調理や加工などへの利用が多く,新品種の育成者権を保護するためには,種苗の適正管理のための調査に加え,加工品や原材料の果実についても育成者権の権利侵害に対する調査が必要であることから,果実や加工品を対象とした品種識別技術の確立が求められている.これまでに開発した生食用カンキツを主な対象としたSNP品種識別技術を基に,主要な香酸カンキツの品種識別に適用できるようにSNPマーカーを新たに設計し,カンキツの9本の染色体の遺伝子型が評価できる10種類のSNPマーカーからなる品種識別用のマ―カーセットを開発した.新たなマーカーセットの利用により,香酸カンキツの10品種と農研機構および徳島県で育成された香酸カンキツ2品種,生食用の73品種を相互に識別できる.分析した85品種には43組合せの親子関係がみられ,トリオ間でSNPの遺伝に矛盾はなかった.また,香酸カンキツの主要品種の果皮,果汁,搾汁酢およびドライフルーツにもこれらのSNPマーカーが適用可能である.本報告で開発したSNP品種識別技術は,生鮮果実などの輸入差止申立に必要な迅速な検査が求められる税関などの検査現場に利用できる実用技術であり,我が国で育成した優良品種の知的財産保護の強化が期待できる.


  • Open Access

    The role of MerTK in promoting cell migration is enhanced by the oncogenic Ras/IL‐33 signaling axis

    by Satoshi Ohta, Kenji Tago, Takahiro Kuchimaru, Megumi Funakoshi‐Tago, Hisanaga Horie, Chihiro Aoki‐Ohmura, Jitsuhiro Matsugi, Ken Yanagisawa

    Ras genes are frequently mutated in many cancer types; however, there are currently no conclusively effective anti-cancer drugs against Ras-induced cancer. Therefore, the downstream effectors of Ras signaling need to be identified for the development of promising novel therapeutic approaches. We previously reported that oncogenic Ras induced the expression of NF-HEV/IL-33, a member of the interleukin-1 family, and showed that intracellular IL-33 was required for oncogenic Ras-induced cellular transformation. In the present study, we demonstrated that the c-Mer proto-oncogene tyrosine kinase (MerTK), a receptor tyrosine kinase, played essential roles in oncogenic Ras/IL-33 signaling. The expression of MerTK was enhanced in transformed NIH-3T3 cells by the expression of oncogenic Ras, H-Ras (G12V), in an IL-33-dependent manner. In human colorectal cancer tissues, MerTK expression also correlated with IL-33 expression. The knockdown of IL-33 or MerTK effectively attenuated the migration of NIH-3T3 cells transformed by H-Ras (G12V) and A549, LoVo and HCT116 cells harboring an oncogenic K-Ras mutation. Furthermore, the suppression of Ras-induced cell migration by the knockdown of IL-33 was rescued by the enforced expression of MerTK. The present results also revealed that MerTK was effectively phosphorylated in NIH-3T3 cells transformed by Ras (G12V). Ras signaling was essential for the tyrosine phosphorylation of MerTK, and the kinase activity of MerTK was indispensable for accelerating cell migration. Collectively, the present results reveal a novel role for MerTK in cancer malignancy, which may be utilized to develop novel therapeutic strategies that target Ras-transformed cells.


  • Open Access

    Oncogenic Ras mutant causes the hyperactivation of NF‐κB via acceleration of its transcriptional activation

    by Kenji Tago, Megumi Funakoshi‐Tago, Satoshi Ohta, Hirotoshi Kawata, Hiroshi Saitoh, Hisanaga Horie, Chihiro Aoki‐Ohmura, Junji Yamauchi, Akira Tanaka, Jitsuhiro Matsugi, et al.

    It is well established that nuclear factor κB (NF‐κB) acts as one of the most important transcription factors for tumor initiation and progression, as it both protects cells from apoptotic/necrotic signals and accelerates angiogenesis and tumor metastasis, which is mediated via the expression of target genes. However, it has not yet been clarified how oncogenic signals accelerate the activation of NF‐κB. In the current study, we utilized untransformed NIH‐3T3 cells stably harboring a κB‐driven luciferase gene to show that an oncogenic mutant of Ras GTPase augmented TNFα‐induced NF‐κB activation. Notably, enforced expression of cyclin‐dependent kinase inhibitors, such as p27Kip1 and p21Cip1, effectively canceled the accelerated activation of NF‐κB, suggesting that oncogenic Ras‐induced cell cycle progression is essential for the hyperactivation of NF‐κB. Furthermore, we found that Ras (G12V) augmented the transcriptional activation of NF‐κB, and this activation required the p38 MAP kinase. We observed that a downstream kinase of p38 MAP kinase, MSK1, was activated by Ras (G12V) and catalyzed the phosphorylation of p65/RelA at Ser‐276, which is critical for its transcriptional activation. Significantly, phosphorylation of the p65/RelA subunit at Ser‐276 was elevated in patient samples of colorectal cancer harboring oncogenic mutations of the K‐Ras gene, and the expression levels of NF‐κB target genes were drastically enhanced in several cancer tissues. These observations strongly suggest that oncogenic signal‐induced acceleration of NF‐κB activation is caused by activation of the p38 MAP kinase–MSK1 signaling axis and by cell cycle progression in cancer cells.


  • Open Access

    Evaluation of Novel Antiviral Agents in the Elimination of Satsuma dwarf virus (SDV) by Semi-micrografting in Citrus

    by Satoshi Ohta, Takeshi Kuniga, Fumie Nishikawa, Atsu Yamasaki, Tomoko Endo, Toru Iwanami, Terutaka Yoshioka

    Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies


  • Acoustic Echo Cancellation Using Sub-Adaptive Filter

    by Satoshi Ohta, Yoshinobu Kajikawa, Yasuo Nomura

    In this paper, we propose an improvement of acoustic echo cancellation (AEC) using sub adaptive filter (sub-ADF). In the acoustic echo cancellation, the step-size parameter of the adaptive filter in AEC must be changed according to the situations where a double talk and an echo path change occur. AEC using the sub-ADF can control the step-size parameter according to the situations. However, this AEC cannot control the step-size parameter appropriately if the double talk and the echo path change simultaneously occur. We therefore propose a novel AEC using the sub-ADF where a double talk detector is introduced. The proposed AEC can realize superior convergence property to the conventional one even when the double talk and the echo path change simultaneously occur. Simulation results demonstrate that the proposed AEC can achieve higher ERLE and faster convergence than the conventional one.


  • Open Access

    Antimyeloperoxidase-antibody-positive rapidly progressive glomerulonephritis associated with Castleman's disease

    by K Furuichi, T Wada, M Shimizu, C Segawa, S Ohta, K Takasawa, K Kobayashi, H Yokoyama

    K Furuichi, T Wada, M Shimizu, C Segawa, S Ohta, K Takasawa, K Kobayashi, H Yokoyama; Antimyeloperoxidase-antibody-positive rapidly progressive glomerulonephri